Evidence map›Paper›PMID 37738440›Full record

ArticleJournal of radiation research2023

Definitive carbon ion re-irradiation with pencil beam scanning in the treatment of unresectable locally recurrent rectal cancer.

Xin Cai, Ping Li, Jingfang Zhao, Weiwei Wang, Jingyi Cheng, Guangyuan Zhang, Sanjun Cai, Zhen Zhang, Guoliang Jiang, Qing Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xin CaiDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Ping LiDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Jingfang ZhaoShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Weiwei WangShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Jingyi ChengShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Guangyuan ZhangShanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
Sanjun CaiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhen ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Guoliang JiangDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Qing ZhangDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Zheng WangDepartment of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
Center for High Pressure Science & Technology Advanced Research · CNFudan University Shanghai Cancer Center · CN

Funding

Shanghai Pudong New Area Heath Commission PW2022A-26
6 · The paper itself

Abstract

This study aimed to evaluate the oncological outcomes and safety of carbon ion re-irradiation with pencil beam scanning (PBS) delivery technique for previously irradiated and unresectable locally recurrent rectal cancer (LRRC). Between June 2017 and September 2021, 24 patients of unresectable LRRC with prior pelvic photon radiotherapy who underwent carbon ion re-irradiation at our institute were retrospectively analyzed. Carbon ion radiotherapy was delivered by raster scanning with a median relative biological effectiveness-weighted dose of 72 Gy in 20 fractions. Weekly CT reviews were carried out, and offline adaptive replanning was performed whenever required. The median follow-up duration was 23.8 months (range, 6.2-47.1 months). At the last follow-up, two patients had a local disease progression, and 11 patients developed distant metastases. The 1- and 2-year local control, progression-free survival and overall survival rates were 100 and 93.3%, 70.8 and 45.0% and 86.7 and 81.3%, respectively. There were no Grade 3 or higher acute toxicities observed. Three patients developed Grade 3 late toxicities, one each with gastrointestinal toxicity, skin reaction and pelvic infection. In conclusion, definitive carbon ion re-irradiation with PBS provided superior oncologic results with tolerable toxicities and may be served as a curative treatment strategy in unresectable LRRC.

Indexed as

Heavy Ion RadiotherapyRectal NeoplasmsRe-IrradiationCarbonHumansNeoplasm Recurrence, LocalRetrospective StudiesCarboncarbon ion radiotherapylocally recurrent rectal cancerpencil beam scanningre-irradiation

Identifiers

PMID37738440
PMCPMC10665299
OpenAlexW4386946759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.